300138 晨光生物
按盤價 
12.900 +0.070 (+0.546%)
12.900 +0.070 (+0.546%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 9.430 | 2.859 | 14.460 | 14.589 | 14.497 |
| 總資產報酬率 ROA (%) | 3.578 | 1.071 | 6.205 | 6.740 | 6.626 |
| 投入資產回報率 ROIC (%) | 3.836 | 1.144 | 6.632 | 7.178 | 7.001 | 邊際利潤分析 |
| 銷售毛利率 (%) | 14.481 | 7.962 | 11.612 | 13.941 | 14.755 |
| 營業利潤率 (%) | 7.305 | 1.516 | 7.980 | 7.735 | 7.897 |
| 息稅前利潤/營業總收入 (%) | 8.140 | 2.562 | 8.778 | 8.331 | 9.210 |
| 淨利潤/營業總收入 (%) | 6.168 | 1.115 | 7.192 | 6.927 | 7.194 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 88.888 | 117.956 | 75.690 | 91.139 | 87.395 |
| 價值變動淨收益/利潤總額(%) | 9.750 | 11.853 | 13.316 | 6.667 | 7.771 |
| 營業外收支淨額/利潤總額(%) | 0.446 | 0.851 | 1.348 | 2.939 | 3.315 | 償債能力分析 |
| 流動比率 (X) | 1.387 | 1.481 | 1.611 | 1.787 | 1.483 |
| 速動比率 (X) | 0.937 | 0.641 | 0.802 | 1.049 | 0.652 |
| 資產負債率 (%) | 57.448 | 65.035 | 58.637 | 53.579 | 53.261 |
| 帶息債務/全部投入資本 (%) | 52.168 | 60.696 | 54.312 | 48.148 | 47.292 |
| 股東權益/帶息債務 (%) | 86.272 | 60.772 | 79.749 | 101.822 | 104.453 |
| 股東權益/負債合計 (%) | 72.918 | 52.992 | 69.308 | 85.313 | 87.821 |
| 利息保障倍數 (X) | 10.145 | 2.480 | 12.737 | 23.063 | 8.838 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 24.447 | 23.489 | 20.087 | 19.923 | 25.436 |
| 存貨周轉天數 (天) | 179.426 | 197.437 | 155.053 | 141.589 | 174.224 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 06/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
